Mats Wahlstrom

TLSI

Mats Wahlstrom serves as director at TriSalus Life Sciences, Inc. (TLSI). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$151.8K

Total Sells

1 trades

$73.9K

Net Position

Net Buyer

$77.9K

Companies Traded

TLSI, CHRS

Active Period

May 2025 – May 2026

2 total trades

Most Recent

Buy TLSI

May 18, 2026 · $151.8K

Mats Wahlstrom's Insider Trading at TriSalus Life Sciences, Inc. (TLSI)

Buys

1 · $151.8K

Sells

0 · $0.00

Total Shares Bought

60,000

Total Shares Sold

TLSI Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 18, 2026	Buy	60,000	$2.53	$151.8K	147,555

Mats Wahlstrom's Insider Trading at Coherus Oncology, Inc. (CHRS)

Buys

0 · $0.00

Sells

1 · $73.9K

Total Shares Bought

Total Shares Sold

99,988

CHRS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 23, 2025	Sell	99,988	$0.74	$73.9K	0

Related Insiders

Richard Marshak

officer: Chief Commercial Officer

TLSISell · May 19, 2026

Michael P Stansky

Director

TLSIBuy · May 18, 2026

Gary B. Gordon

director

TLSIBuy · May 18, 2026

Mary T Szela

director, officer: CEO and President

TLSIBuy · May 18, 2026

David Patience

officer: Chief Financial Officer

TLSIBuy · May 18, 2026

Bryan F. Cox

officer: Chief of Research

TLSISell · Mar 20, 2026

Jodi Devlin

officer: Chief of Clinical Operations

TLSISell · Mar 20, 2026

Jennifer Stevens

officer: Chief Regulatory Officer

TLSISell · Mar 20, 2026

Explore More Insider Trading Data

TLSI Insider Trading Activity

View all insider trades at TriSalus Life Sciences, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity